{"entity":{"id":"protein-alkylator-payloads","kind":"term","name":"Protein-alkylating payloads","aka":["PA289","ProAlk payloads","cytosolic protein alkylator payloads"],"tldr":"These experimental payloads are proposed to kill cells by chemically modifying proteins. The reported mechanism is still being investigated.","summary":"An AACR abstract described PA289, a seco-CBI-based prodrug linker-payload with a glucuronide trigger. The authors proposed alkylation of one or more cytosolic proteins and reported activity in cell and xenograft experiments, with exploratory monkey toxicology. The protein target was not established in the abstract. Protein alkylation should remain an attributed mechanism hypothesis, not be silently recast as proven DNA alkylation or human safety.","asOf":"2026-11-08","links":[{"label":"Mysliwy et al., PA289 preclinical AACR abstract (2025)","url":"https://doi.org/10.1158/1538-7445.AM2025-1579"}],"tags":[],"related":[],"cancers":[],"sections":[],"technologies":["adc"],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":["payload"],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"category":"ADC chemistry"},"route":"/terms/protein-alkylator-payloads/","neighbours":{"technology":[{"id":"adc","kind":"technology","name":"Antibody-drug conjugate (ADC)","route":"/technologies/adc/"}],"term":[{"id":"next-generation-adc-payloads","kind":"term","name":"Next-generation antibody-conjugate payloads","route":"/terms/next-generation-adc-payloads/"},{"id":"payload","kind":"term","name":"Payload (ADC)","route":"/terms/payload/"}]}}